Ebola virus VP35 hijacks the PKA-CREB1 pathway for replication and pathogenesis by AKIP1 association
- Nat Commun. 2022 Apr 26;13(1):2256. doi: 10.1038/s41467-022-29948-4.
- 1. Beijing Institute of Biotechnology, Beijing, 100039, China.
- 2. National Biosafety Laboratory, Chinese Academy of Sciences, Wuhan, Hubei, 430020, China.
- 3. Institute of Physical Science and Information Technology, Anhui University, Hefei, Anhui, 230601, China.
- 4. State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, 430072, China.
- 5. Insitut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, 200031, China.
- 6. National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China.
- 7. Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, 130000, China.
- 8. National Biosafety Laboratory, Chinese Academy of Sciences, Wuhan, Hubei, 430020, China. [email protected].
- 9. Beijing Institute of Biotechnology, Beijing, 100039, China. [email protected].
- 10. Beijing Institute of Biotechnology, Beijing, 100039, China. [email protected].
- # Contributed equally.
Ebola virus (EBOV), one of the deadliest viruses, is the cause of fatal Ebola virus disease (EVD). The underlying mechanism of viral replication and EBOV-related hemorrhage is not fully understood. Here, we show that EBOV VP35, a cofactor of viral RNA-dependent RNA polymerase, binds human A kinase interacting protein (AKIP1), which consequently activates protein kinase A (PKA) and the PKA-downstream transcription factor CREB1. During EBOV Infection, CREB1 is recruited into EBOV ribonucleoprotein complexes in viral inclusion bodies (VIBs) and employed for viral replication. AKIP1 depletion or PKA-CREB1 inhibition dramatically impairs EBOV replication. Meanwhile, the transcription of several coagulation-related genes, including THBD and SERPINB2, is substantially upregulated by VP35-dependent CREB1 activation, which may contribute to EBOV-related hemorrhage. The finding that EBOV VP35 hijacks the host PKA-CREB1 signal axis for viral replication and pathogenesis provides novel potential therapeutic approaches against EVD.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Epigenetic Reader DomainResearch Areas: Cancer